RCM & Prior Auth AI
W

Waystar

Indexed for the AltitudeAI product suite rather than for the underlying revenue cycle platform, which is treated as context under this index's product scoping rule. AltitudeAI, launched January 2025, brings the company's AI capabilities under one brand across a cloud based RCM platform serving a reported one million providers and processing more than six billion transactions annually, reaching roughly half of US patients. AltitudeCreate applies generative AI to autonomously draft appeal letters for denied claims, drawing on a library of more than 1,100 payer specific appeal templates. AltitudePredict uses predictive analytics to score and prioritize denied claims by expected cash value and likelihood of being overturned. AltitudeAssist, in Claim Manager, converts user prompts into automated denial prevention recommendations that fix issues before submission, which the company reports compresses a three day process to roughly three minutes. The company reports early AltitudeAI results of appeal package creation three times faster, saving about 16 minutes per package. Publicly traded (NASDAQ: WAY).

Last VerifiedJuly 19, 2026
Founded
Headquarters
Louisville, Kentucky
Website
www.waystar.com
Categories
rcm-and-prior-auth, healthcare-admin-automation
Indexed Products
AltitudeAI, AltitudeCreate, AltitudePredict, AltitudeAssist
Buyer Segments
Large IDN, Community Health System, Medical Group, Independent Practice
Assessment

Capability Axes

AI Capability
AI Centrality
C
Vendor Published

The second reference case for this grade, alongside Elation Health, and it is descriptive rather than critical. AltitudeCreate, AltitudePredict, and AltitudeAssist are genuine shipping AI products, but what a provider organization buys is a revenue cycle platform that clears claims; the AI accelerates workflows inside a system whose value stood before it. No organization purchases Waystar for AltitudeAI alone. That is the material fact when weighing bundled incumbent AI against a specialist tool such as Tennr or Plenful.

Autonomy and Oversight Model
C
Vendor Published

The autonomy claim is unusually strong and the oversight disclosure unusually thin, which is the combination this axis penalizes. The company describes AltitudeCreate as autonomously generating appeal letters, documents that are submitted to payers and constitute assertions about medical necessity and coverage. No published review step, confidence threshold, escalation path, or accuracy rate for generated appeals was retrieved. A buyer should establish who reviews an autonomously drafted appeal before submission, what happens when one contains an error, and whether the 1,100 payer specific templates constrain the generation or merely seed it.

Model and Technology Transparency
Not rated
Clinical and Operational Evidence
B
Vendor Published

Operational figures are specific, recent, and tied to defined workflows rather than asserted generally: appeal package creation reported three times faster with about 16 minutes saved per package, a roughly 70 percent time reduction, and denial prevention recommendations compressing a three day process to approximately three minutes. Network scale is corroborated by the company's public filings at more than six billion annual transactions across a reported one million providers. Held back from A because the figures are vendor measured without published methodology or an independent comparison, and time saved is an input metric rather than a recovery outcome.

AI Safety and PHI Stewardship
Not rated
Regulatory and Compliance
HIPAA and BAA Posture
Not rated
Security Certifications and Trust Center
B
Third Party Estimated

Third party listings report HIPAA, HITRUST, SOC 2, and PCI DSS certifications, a broad set appropriate to a company processing payment as well as clinical data, with PCI DSS reflecting the payments side specifically. Held back from A because the certifications were verified through third party sources rather than a vendor trust center with named audit dates and scope.

FDA and Regulatory Status
Not rated
AI Governance and Bias Disclosure
Not rated
Integration and Deployment
EHR and Interoperability Depth
A
Vendor Published

Reach is the defining asset. The payments network is reported to process more than six billion transactions annually for approximately one million providers, touching roughly half of US patients, which gives the predictive models a data advantage a point solution cannot assemble. Integration spans provider systems and payer connections rather than a single EHR.

Deployment Model and Data Residency
Not rated
Commercial
Commercial Transparency
Not Rated
Third Party Estimated

No public pricing. Contact the vendor. Third party sources describe subscription pricing scaled by organization size, claim volume, and feature set, and note that AltitudeAI capabilities sit within the enterprise platform rather than being separately listed. Buyers should establish whether AI capabilities carry incremental cost or are bundled, since that determines the comparison against a separately priced specialist tool.

Setting and Specialty Coverage
Not rated
Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Contact the vendor
Enterprise subscription scaled by organization size, claim volume, and feature set Third Party Estimated

No rate card published. Third party sources describe a subscription model scaled by organization size, claim volume, and feature set, with AltitudeAI capabilities positioned inside the enterprise platform rather than listed separately. The decisive procurement question is whether the AI capabilities carry incremental cost or are bundled into the platform subscription, since that determines how the option compares against a separately priced specialist tool in the same workflow.

AI Health Index

An independent reference for evaluating AI vendors in healthcare. No vendor pays for inclusion, placement, or rating.

Index Status
Last index update
July 19, 2026
The AI Health Index is an editorial reference, not a regulatory body. Vendor data is verified against published sources and public regulatory filings. Figures labeled “Estimated” have not been confirmed by the vendor. See the Methodology page for evaluation standards and limitations.
© 2026 AI Health Index
3801 N Capital of Texas Hwy, Ste E240 · Austin, TX 78746